Replies to post #253851 on Avid Bioservices Inc (CDMO)

[biopharm]

We see good evidence that the combination of bavituximab with ribavirin has a better safety profile than an interferon containing regimen which was one of the primary objectives of the study," said Joseph S. Shan, vice president of clinical and regulatory affairs at Peregrine Pharmaceuticals.

Do all new BODs have 100% complete access to all information in regards to PS Targeting, including all Ribavirin vs Bavituximab comparison type data and ALL FDA data?

Send a certified letter to FDA requesting if any emails have been lost or data been breached and ask the new BODs if they have VERIFIED the matching of all data records to verify they have everything and IF they say yes and FDA says nothing missing or data breached ...etc there will be no excuses later on

Get those certified letters in TODAY